Streetbeat News

Price Targets

THC

Keybanc has initiated coverage on Tenet Healthcare with an Overweight rating and set a price target of $200.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 4:07 pm

PRVA

Keybanc analyst Matthew Gillmor has initiated coverage on Privia Health Group (NASDAQ:PRVA) with an Overweight rating and set a price target of $23.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 4:01 pm

CF

Analysts have varied ratings for CF Industries Holdings, with recent shifts towards more bullish sentiments. The average 12-month price target has increased by 5.5% to $88.46. Analysts have adjusted their ratings and price targets, reflecting changing market dynamics and company performance. Despite a decline in revenue, CF Industries shows strong profitability and financial health, though it has a higher debt-to-equity ratio than industry averages.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 4:01 pm

WMT

The article provides an in-depth analysis of 34 analyst recommendations for Walmart (NYSE:WMT), highlighting a range of opinions from bullish to bearish. Recent analyst actions show a trend of raised price targets and ratings, with an average 12-month price target of $83.06, reflecting a 9.68% increase from the previous average. Walmart's financial performance is strong, with positive revenue growth, high net margins, and effective debt management.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 4:00 pm

ACHC

Acadia Healthcare Co (NASDAQ:ACHC) has been analyzed by 10 analysts, showing a range of sentiments from bullish to bearish. The average 12-month price target is $86.8, slightly down from $87.60. Analysts have maintained or adjusted ratings, reflecting their views on the company's performance. Acadia Healthcare Co has shown solid revenue growth and strong net margins, but faces challenges with asset utilization.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 4:00 pm

VTR

In the past three months, 9 analysts have rated Ventas (NYSE:VTR), with most being somewhat bullish. The average 12-month price target has increased by 11.48% to $64.78. Analysts have raised their ratings and price targets, reflecting positive sentiment. Ventas has shown strong revenue growth and financial performance, though its ROE is below industry benchmarks.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 4:00 pm

ACDC

ProFrac Holding (NASDAQ:ACDC) has received mixed analyst evaluations over the past three months, with a decrease in average price target from $9.38 to $7.88. Analysts have adjusted their ratings and price targets, reflecting changing market dynamics and company performance. ProFrac faces challenges with declining revenue, low net margin, and below-average ROE and ROA.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 4:00 pm

APD

Wells Fargo analyst Michael Sison maintains an Equal-Weight rating on Air Products & Chemicals (NYSE:APD) and raises the price target from $280 to $330.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 3:56 pm

HCA

Keybanc analyst Matthew Gillmor has initiated coverage on HCA Healthcare with an Overweight rating and set a price target of $475.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 3:51 pm

WMT

UBS analyst Michael Lasser has maintained a Buy rating on Walmart and raised the price target from $81 to $92.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 3:50 pm